PETMED EXPRESS INC 8-K

What Happened

• Petmed Express, Inc. (PETS) filed an 8-K on Jan 23, 2026 reporting the results of its Annual Meeting held Jan 21, 2026. As of the Dec 5, 2025 record date there were 21,372,021 shares outstanding; 15,506,165 shares were represented (quorum).
• The board’s five director nominees were elected. Final votes (For / Against / Abstentions / Broker non‑votes):
  • Peter Batushansky: 7,250,849 / 3,099,547 / 49,472 / 5,106,297
  • Leslie C.G. Campbell: 6,861,234 / 3,462,355 / 76,277 / 5,106,299
  • James LaCamp: 7,297,434 / 2,888,574 / 213,859 / 5,106,298
  • Justin Mennen: 7,032,944 / 3,316,791 / 50,134 / 5,106,296
  • Leah A. Solivan: 7,239,551 / 3,111,757 / 48,559 / 5,106,298

Key Details

• Record date shares outstanding: 21,372,021 (Dec 5, 2025). Shares represented at meeting: 15,506,165.
• Advisory vote on executive compensation (say‑on‑pay): For 8,530,380 / Against 1,787,060 / Abstentions 82,428 / Broker non‑votes 5,106,297.
• Auditor ratified: Baker Tilly US, LLP was ratified as the company’s independent registered public accounting firm for fiscal 2026 — For 14,979,224 / Against 448,313 / Abstentions 78,628 / Broker non‑votes 2.

Why It Matters

• The election results maintain the board’s proposed leadership, which affects company oversight and strategic continuity.
• The say‑on‑pay approval (advisory) indicates shareholder support for executive compensation disclosed in the proxy.
• Ratification of Baker Tilly as auditor confirms the firm that will review Petmed’s 2026 financials.
• No other material changes (e.g., executive departures, mergers, or financial results) were reported in this filing.